Harlem Prevention Center CRS

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• HIV3 trials

Phase

• Phase 2/32 trials
• Phase 21 trial

Status

• Completed2 trials
• Active, not recruiting1 trial

Lead sponsor

• Gilead Sciences1 trial
• HIV Prevention Trials Network1 trial
• National Institute of Allergy and Infectious Diseases (NIAID)1 trial

Running trials

• Active, not recruiting

  Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) in Prevention of HIV in Cisgender Women in the United States (HPTN 102)

  NCT06101329· Phase 2· Gilead Sciences· Source

Closed trials

• Completed

  Pre-Exposure Prophylaxis for Transgender Women in the US and South America

  NCT04742491· Phase 2/3· HIV Prevention Trials Network· Source

• Completed

  Injectable Cabotegravir Compared to TDF/FTC For PrEP in HIV-Uninfected Men and Transgender Women Who Have Sex With Men

  NCT02720094· Phase 2/3· National Institute of Allergy and Infectious Diseases (NIAID)· Source